Gujarat Kidney and Super Speciality IPO
GKSL
Open Date
22 Dec '25
Close Date
24 Dec '25
Price Range
₹108 - ₹114
Min Investment
₹14,592
Lot Size
128
Listing at
NSE
Issue Size
1,32,26,880
IPO Document
Free Demat with Zero AMC*
About Gujarat Kidney and Super Speciality Ltd IPO
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
- Secondary Care Services: General and surgical treatments.
- Tertiary Care Services: Super speciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Competitive Strengths:
- Pre-eminence in renal sciences, with established sub-superspecialities in urology
- Asset light business model with focus in central region of Gujarat
- Ability to attract, retain skilled and experienced quality medical professionals
- Track record of operating and financial performance and growth
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operat
Gujarat Kidney and Super Speciality IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 75% | 99,20,160 crores |
| Non-Institutional Investors (NIIs) | 15% | 19,84,032 crores |
| Retail Individual Investors (RIIs) | 10% | 13,22,688 crores |
Gujarat Kidney and Super Speciality IPO Strengths & Weaknesses
No Data Found
Gujarat Kidney and Super Speciality IPO Important Dates & Issue Details
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 26 Dec '25 | 30 Dec '25 | 29 Dec '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 1,32,26,880 shares (aggregating up to ₹14,592 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
Gujarat Kidney and Super Speciality IPO Lot Size and Investment Details
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Gujarat Kidney and Super Speciality ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Gujarat Kidney and Super Speciality IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Gujarat Kidney and Super Speciality Lead Manager(s)
| Book Running Lead Manager(s) |
|---|